Effects of ginseng on Pseudomonas aeruginosa motility and biofilm formation

FEMS Immunology and Medical Microbiology

Volumn 62, Issue 1, 2011, Pages 49-56

  Wu, Hong ^a   Lee, Baoleri ^a   Yang, Liang ^b   Wang, Hengzuang ^a   Givskov, Michael ^c   Molin, Søren ^b,d   Høiby, Niels ^a,c,d   Song, Zhijun ^a  

^a Rigshospitalet   (Denmark)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d ESCMID Study Group for Biofilms   (Denmark)

Author keywords

Biofilm; Ginseng; Motility; Mouse; Pseudomonas aeruginosa

Indexed keywords

GINSENG EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BIOFILM; CELL MOTILITY; CONTROLLED STUDY; FEMALE; GINSENG; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SWIMMING; TWITCHING MOTILITY;

ANIMALS; BIOFILMS; CELL MOVEMENT; CYSTIC FIBROSIS; HUMANS; MICE; PANAX; PHAGOCYTOSIS; PLANT EXTRACTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TREATMENT OUTCOME;

EID: 79954992451     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2011.00787.x     Document Type: Article

References (46)

1. Barken KB, Pamp SJ, Yang L et al. (2008) Roles of type IV pili, flagellum-mediated motility and extracellular DNA in the formation of mature multicellular structures in Pseudomonas aeruginosa biofilms. Environ Microbiol 10: 2331-2343.
2. Clark DJ & Maaløe O (1967) DNA replication and the division cycle in Escherichia coli. J Mol Biol 23: 99-112.
3. Deziel E, Lepine F, Milot S & Villemur R (2003) rhlA is required for the production of a novel biosurfactant promoting swarming motility in Pseudomonas aeruginosa: 3-(3-hydroxyalkanoyloxy)alkanoic acids (HAAs), the precursors of rhamnolipids. Microbiology 149: 2005-2013.
4. Flemming HC, Neu TR & Wozniak DJ (2007) The EPS matrix: the 'house of biofilm cells'. J Bacteriol 189: 7945-7947.
5. Hentzer M, Teitzel GM, Balzer GJ, Heydorn A, Molin S, Givskov M & Parsek MR (2001) Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function. J Bacteriol 183: 5395-5401.
6. Hentzer M, Wu H, Andersen JB et al. (2003) Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. EMBO J 22: 3803-3815.
7. Hoffmann N, Rasmussen TB, Jensen PO et al. (2005) Novel mouse model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis. Infect Immun 73: 2504-2514.
8. Høiby N, Krogh Johansen H, Moser C, Song Z, Ciofu O & Kharazmi A (2001) Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth. Microbes Infect 3: 23-35.
9. Høiby N, Frederiksen B & Pressler T (2005) Eradication of early Pseudomonas aeruginosa infection. J Cyst Fibros 4 (suppl 2): 49-54.
10. Høiby N, Bjarnsholt T, Givskov M, Molin S & Ciofu O (2010) Antibiotic resistance of bacterial biofilms. Int J Antimicrob Ag 35: 322-332.
11. Holloway BW & Morgan AF (1986) Genome organization in Pseudomonas. Annu Rev Microbiol 40: 79-105.
12. Huang KC (1993) Herbs with multiple actions. The Pharmacology of Chinese Herbs (Waddell WJ, ed), pp. 21-45. CRC Press, Boca Raton, FL.
13. Johansen HK, Hougen HP, Cryz SJ Jr, Rygaard J & Høiby N (1995) Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia in rats. Am J Respir Crit Care 152: 1337-1346.
14. Johansen HK, Hougen HP, Rygaard J & Høiby N (1996) Interferon-gamma (IFN-gamma) treatment decreases the inflammatory response in chronic Pseudomonas aeruginosa pneumonia in rats. Clin Exp Immunol 103: 212-218.
15. Johansen HK, Cryz SJ Jr, Hougen HP, Moser C & Høiby N (1997) Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle. Behring Inst Mitt 98: 269-273.
16. Klausen M, Heydorn A, Ragas P, Lambertsen L, Aaes-Jorgensen A, Molin S & Tolker-Nielsen T (2003) Biofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants. Mol Microbiol 48: 1511-1524.
17. Kohler T, Curty LK, Barja F, van Delden C & Pechere JC (2000) Swarming of Pseudomonas aeruginosa is dependent on cell-to-cell signaling and requires flagella and pili. J Bacteriol 182: 5990-5996.
18. Lee B, Haagensen JA, Ciofu O, Andersen JB, Høiby N & Molin S (2005) Heterogeneity of biofilms formed by nonmucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis. J Clin Microbiol 43: 5247-5255.
19. Lyczak JB, Cannon CL & Pier GB (2000) Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect 2: 1051-1060.
20. Mathee K, Ciofu O, Sternberg C et al. (1999) Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung. Microbiology 145: 1349-1357.
21. Mattick JS (2002) Type IV pili and twitching motility. Annu Rev Microbiol 56: 289-314.
22. Moser C, Johansen HK, Song Z, Hougen HP, Rygaard J & Høiby N (1997) Chronic Pseudomonas aeruginosa lung infection is more severe in Th2 responding BALB/c mice compared to Th1 responding C3H/HeN mice. APMIS 105: 838-842.
23. Moser C, Kjaergaard S, Pressler T, Kharazmi A, Koch C & Høiby N (2000) The immune response to chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is predominantly of the Th2 type. APMIS 108: 329-335.
24. Moser C, Jensen PO, Pressler T et al. (2005) Serum concentrations of GM-CSF and G-CSF correlate with the Th1/Th2 cytokine response in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. APMIS 113: 400-409.
25. O'May CY, Sanderson K, Roddam LF, Kirov SM & Reid DW (2009) Iron-binding compounds impair Pseudomonas aeruginosa biofilm formation, especially under anaerobic conditions. J Med Microbiol 58: 765-773.
26. O'Toole GA & Kolter R (1998) Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol Microbiol 30: 295-304.
27. Overhage J, Bains M, Brazas MD & Hancock RE (2008) Swarming of Pseudomonas aeruginosa is a complex adaptation leading to increased production of virulence factors and antibiotic resistance. J Bacteriol 190: 2671-2679.
28. Pamp SJ & Tolker-Nielsen T (2007) Multiple roles of biosurfactants in structural biofilm development by Pseudomonas aeruginosa. J Bacteriol 189: 2531-2539.
29. Pamp SJ, Gjermansen M, Johansen HK & Tolker-Nielsen T (2008) Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes. Mol Microbiol 68: 223-240.
30. Semmler AB, Whitchurch CB & Mattick JS (1999) A re-examination of twitching motility in Pseudomonas aeruginosa. Microbiology 145: 2863-2873.
31. Shrout JD, Chopp DL, Just CL, Hentzer M, Givskov M & Parsek MR (2006) The impact of quorum sensing and swarming motility on Pseudomonas aeruginosa biofilm formation is nutritionally conditional. Mol Microbiol 62: 1264-1277.
32. Singh PK, Parsek MR, Greenberg EP & Welsh MJ (2002) A component of innate immunity prevents bacterial biofilm development. Nature 417: 552-555.
33. Song Z, Johansen HK, Faber V, Moser C, Kharazmi A, Rygaard J & Høiby N (1997a) Ginseng treatment reduces bacterial load and lung pathology in chronic Pseudomonas aeruginosa pneumonia in rats. Antimicrob Agents Ch 41: 961-964.
34. Song Z, Kharazmi A, Wu H et al. (1998) Effects of ginseng treatment on neutrophil chemiluminescence and immunoglobulin G subclasses in a rat model of chronic Pseudomonas aeruginosa pneumonia. Clin Diagn Lab Immun 5: 882-887.
35. Song Z, Wu H, Mathee K, Høiby N & Kharazmi A (2002) Gerimax ginseng regulates both humoral and cellular immunity during chronic Pseudomonas aeruginosa lung infection. J Altern Complem Med 8: 459-466.
36. Song Z, Wu H, Ciofu O et al. (2003) Pseudomonas aeruginosa alginate is refractory to Th1 immune response and impedes host immune clearance in a mouse model of acute lung infection. J Med Microbiol 52: 731-740.
37. Song Z, Moser C, Wu H et al. (2005) Ginseng modulates the immune response via its effect on cytokine production-secondary publication. Ugeskr Laeger 167: 3054-3056.
38. Song Z, Kong KF, Wu H et al. (2010) Panax ginseng has anti-infective activity against opportunistic pathogen Pseudomonas aeruginosa by inhibiting quorum sensing, a bacterial communication process critical for establishing infection. Phytomedicine 17: 1040-1046.
39. Song ZJ, Johansen HK, Faber V & Høiby N (1997b) Ginseng treatment enhances bacterial clearance and decreases lung pathology in athymic rats with chronic Pseudomonas aeruginosa pneumonia. APMIS 105: 438-444.
40. Sternberg C & Tolker-Nielsen T (2006) Growing and analyzing biofilms in flow cells. Curr Protoc Microbiol 1B.2.1-1B.2.15.
41. Stewart PS & Costerton JW (2001) Antibiotic resistance of bacteria in biofilms. Lancet 358: 135-138.
42. Stoodley P, Sauer K, Davies DG & Costerton JW (2002) Biofilms as complex differentiated communities. Annu Rev Microbiol 56: 187-209.
43. Wu H, Song Z, Givskov M et al. (2001) Pseudomonas aeruginosa mutations in lasI and rhlI quorum sensing systems result in milder chronic lung infection. Microbiology 147: 1105-1113.
44. Yang L, Barken KB, Skindersoe ME, Christensen AB, Givskov M & Tolker-Nielsen T (2007) Effects of iron on DNA release and biofilm development by Pseudomonas aeruginosa. Microbiology 153: 1318-1328.
45. Yang L, Nilsson M, Gjermansen M, Givskov M & Tolker-Nielsen T (2009a) Pyoverdine and PQS mediated subpopulation interactions involved in Pseudomonas aeruginosa biofilm formation. Mol Microbiol 74: 1380-1392.
46. Yang L, Rybtke MT, Jakobsen TH, Hentzer M, Bjarnsholt T, Givskov M & Tolker-Nielsen T (2009b) Computer-aided identification of recognized drugs as Pseudomonas aeruginosa quorum-sensing inhibitors. Antimicrob Agents Ch 53: 2432-2443.